James T Mccracken MD

Child & Adolescent Psychiatry, Psychopharmacology

Professor of Child Psychiatry and Director of the Division of Child and Adolescent Psychiatry at the UCLA NPI-Semel Institute (formerly the Neuropsychiatric Institute) in Los Angeles

Join to View Full Profile

UCSF Department of Psychiatry and Behavioral Sciences675 18th Street Box 5326San Francisco, CA 94143
Phone+1 415-514-5743

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Child and Adolescent Psychiatry, 1984 - 1987
Duke University HospitalResidency, Psychiatry, 1980 - 1984
Baylor College of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1985 - 2026
NC State Medical License 1982 - 1988
TX State Medical License 1980 - 1988
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Treatment of Autism in Children and Adolescents Start of enrollment: 1997 Oct 01
Completed
Phase 3
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder Start of enrollment: 2007 Jan 01
Completed
Phase 4
Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders Start of enrollment: 2007 Jul 01
Completed
Not Applicable
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
Completed
Phase 2
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
Completed
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders Start of enrollment: 2009 Feb 01
Completed
Phase 2
Biomarker and DNA Collection in Subjects Participating in Protocol 22003 Start of enrollment: 2009 May 01
Completed
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder Start of enrollment: 2011 Dec 01
Completed
Phase 4
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial Start of enrollment: 2013 Oct 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Pupillary unrest is attenuated in attention deficit hyperactivity disorder (ADHD).
Claudio M Privitera, Sean Noah, Thom Carney, Stanley A Klein, Agatha Lenartowicz
Neuroscience Letters. 2025-03-10
3 citations
Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms.
Julia N Stimpfl, John T Walkup, Adelaide S Robb, Alexandra E Alford, Stephen M Stahl
Journal of Child and Adolescent Psychopharmacology. 2025-02-01
Sex Differences in the Brain's White Matter Microstructure during Development assessed using Advanced Diffusion MRI Models.
Sebastian M Benavidez, Zvart Abaryan, Gaon S Kim, Emily Laltoo, James T McCracken
Biorxiv. 2024-04-30

Journal Articles

In Search of Biomarkers for Autism Spectrum Disorder
Eric Hollander, James T McCracken, Autism Research

Authored Content

Targeted Family Intervention for Complex Cases of Pediatric Obsessive-Compulsive Disorder: A Randomized Controlled TrialOctober 2017

Press Mentions

Emerald Health Therapeutics Announces Advisory Board; Plans Clinical ResearchJune 14th, 2017
Guts, Genes, and Brains Highlight Expert DebatesMarch 15th, 2017

Grant Support

Training the Science of Child Mental Health TreatmentUNIVERSITY OF CALIFORNIA LOS ANGELES2006–2027
Training the Science of Child Mental Health TreatmentUNIVERSITY OF CALIFORNIA LOS ANGELES2006–2027
New Experimental Medicine Studies: Fast-Fail Trials in Autism Spectrum DisordersNational Institute of Mental Health2012–Present
3/4-Rupp Autism Network: Guanfacine For The Treatment Of Hyperactivity In PDDNational Institute Of Mental Health2010–2011
Cidar: Translational Research To Enhance Cognitive Control (TRECC)National Institute Of Mental Health2006–2011
OCD Collaborative Genetics Association StudyNational Institute Of Mental Health2007–2010
Mexican American Obese Children StudyNational Center For Research Resources2007–2010
Follow UP Of The PATS SampleNational Institute Of Mental Health2004–2008
Drug Response In Pediatric PsychopharmacologyNational Institute Of Mental Health2001–2005
Methylphenidate Efficacy And Safety In ADHD PreschoolersNational Institute Of Mental Health2000–2003
Neuroanatomical &Functional Aspects Of Attention Deficit Hyperactivity DisorderNational Institute Of Mental Health2002
Research Units On Pediatric Psychopharmacology--AutismNational Institute Of Mental Health1997–2000
Hormone Rhythms--Metabolic Significance In DepressionNational Center For Research Resources1992–1993
Sleep And Hormone Regulation In Juvenile DepressionNational Center For Research Resources1992
Sleep &Hormone Regulation In Juvenile DepressionNational Institute Of Mental Health1991
Developmental Aspects Of Antidepressant ResponsesNational Institute Of Mental Health1991
Hormone Rhythms--Metabolic Significance In DepressionNational Center For Research Resources1990–1991
Sleep And Hormone Regulation In Juvenile DepressionNational Center For Research Resources1989–1991
Developmental Aspects Of Antidepressant ResponsesNational Institute Of Mental Health1990
Development Aspects Of Serotonergic Control Of The HPA AxisNational Center For Research Resources1990
Sleep &Hormone Regulation In Juvenile DepressionNational Institute Of Mental Health1987–1990

Professional Memberships

American Psychiatric Association - APA
Fellow